Banys-Paluchowski, Malgorzata
Milde-Langosch, Karin
Fehm, Tanja
Witzel, Isabell
Oliveira-Ferrer, Leticia
Schmalfeldt, Barbara
Müller, Volkmar
Article History
Received: 14 September 2019
Accepted: 10 October 2019
First Online: 23 October 2019
Compliance with ethical standards
:
: MBP received lecture honoraria or consultant fees from Roche, Novartis, Eli Lilly, Eisai, and Pfizer. VM received speaker honoraria from Amgen, AstraZeneca, Celgene, Daiichi-Sankyo, Eisai, Pfizer, Pierre Fabre, Novartis, Roche, Teva, and Janssen-Cilag, and served as a consultant/advisor to Genomic Health, Roche, Pierre Fabre, Amgen, Daiichi-Sankyo, and Eisai, and received research grants from Genomic Health, Roche, Pierre Fabre, Amgen, Daiichi-Sankyo, and Eisai. IW received honoraria from MSD, Roche, Pfizer, Novartis, and Daichii Sankyo. TF, BS, LOF, KLM declare no competing interests.
: Informed consent was obtained from all individual participants included in this study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Ethik-Kommission der Ärztekammer Hamburg, #OB/V/03) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The experiments conducted within this study comply with the current laws of the country in which they were performed.